* Omnicell Inc OMCL.OQ reported quarterly adjusted
earnings of
51 cents per share for the quarter ended in June, lower than
the same quarter last year, when the company reported EPS of 57
cents. The mean expectation of nine analysts for the quarter
was for earnings of 14 cents per share. Wall Street expected
results to range from 10 cents to 18 cents per share.
* Revenue fell 7.4% to $276.79 million from a year ago;
analysts
expected $255.20 million.
* Omnicell Inc's reported EPS for the quarter was 8 cents.
* The company reported quarterly net income of $3.74
million.
* Omnicell Inc shares had risen by 7.9% this quarter and
lost 22.4% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 16.6%
in the last three months.
* In the last 30 days, there have been no negative revisions
of
earnings estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 4
"hold" and 1 "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "hold"
Wall Street's median 12-month price target for Omnicell Inc is
$36.00
This summary was machine generated from LSEG data August 1 at
01:30 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 0.14 0.51 Beat
Mar. 31 2024 -0.09 0.03 Beat
Dec. 31 2023 0.15 0.33 Beat
Sep. 30 2023 0.47 0.62 Beat